Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 28708 | 164 | 45.2 | 88% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 356 | 16803 | PROTEOMICS//JOURNAL OF PROTEOME RESEARCH//PROTEIN IDENTIFICATION |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | VASC PHYSIOPATHOL | Address | 1 | 21% | 3% | 5 |
| 2 | MEDIA LAYER | Author keyword | 1 | 40% | 1% | 2 |
| 3 | CORONARY ATHEROSCLEROTIC HEART DISEASE | Author keyword | 1 | 33% | 1% | 2 |
| 4 | AORTA PROTEOME | Author keyword | 1 | 50% | 1% | 1 |
| 5 | APO E KNOCK OUT MICE | Author keyword | 1 | 50% | 1% | 1 |
| 6 | BIOMED SCI BIOTECHNOL HUMAN ANAT | Address | 1 | 50% | 1% | 1 |
| 7 | EXTRACELLULAR REMODELLING | Author keyword | 1 | 50% | 1% | 1 |
| 8 | INTERNATIONAL EFFORTS | Author keyword | 1 | 50% | 1% | 1 |
| 9 | INTERVENTION POTENTIAL | Author keyword | 1 | 50% | 1% | 1 |
| 10 | INTIMA LAYER | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | MEDIA LAYER | 1 | 40% | 1% | 2 | Search MEDIA+LAYER | Search MEDIA+LAYER |
| 2 | CORONARY ATHEROSCLEROTIC HEART DISEASE | 1 | 33% | 1% | 2 | Search CORONARY+ATHEROSCLEROTIC+HEART+DISEASE | Search CORONARY+ATHEROSCLEROTIC+HEART+DISEASE |
| 3 | AORTA PROTEOME | 1 | 50% | 1% | 1 | Search AORTA+PROTEOME | Search AORTA+PROTEOME |
| 4 | APO E KNOCK OUT MICE | 1 | 50% | 1% | 1 | Search APO+E+KNOCK+OUT+MICE | Search APO+E+KNOCK+OUT+MICE |
| 5 | EXTRACELLULAR REMODELLING | 1 | 50% | 1% | 1 | Search EXTRACELLULAR+REMODELLING | Search EXTRACELLULAR+REMODELLING |
| 6 | INTERNATIONAL EFFORTS | 1 | 50% | 1% | 1 | Search INTERNATIONAL+EFFORTS | Search INTERNATIONAL+EFFORTS |
| 7 | INTERVENTION POTENTIAL | 1 | 50% | 1% | 1 | Search INTERVENTION+POTENTIAL | Search INTERVENTION+POTENTIAL |
| 8 | INTIMA LAYER | 1 | 50% | 1% | 1 | Search INTIMA+LAYER | Search INTIMA+LAYER |
| 9 | SYNTHETIC GEL | 1 | 50% | 1% | 1 | Search SYNTHETIC+GEL | Search SYNTHETIC+GEL |
| 10 | VASCULAR PROTEOMICS | 1 | 50% | 1% | 1 | Search VASCULAR+PROTEOMICS | Search VASCULAR+PROTEOMICS |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CIRCULATING HUMAN MONOCYTES | 5 | 55% | 4% | 6 |
| 2 | E O MICE | 4 | 75% | 2% | 3 |
| 3 | DELTA NULL MICE | 2 | 50% | 2% | 3 |
| 4 | BIORESORBABLE STENT MATERIALS | 1 | 100% | 1% | 2 |
| 5 | SMOOTH MUSCLE PROTEINS | 1 | 50% | 1% | 2 |
| 6 | TISSUE PROTEOMICS | 1 | 27% | 2% | 4 |
| 7 | CHIMERIC HAMMERHEAD RIBOZYME | 1 | 50% | 1% | 1 |
| 8 | HUMAN ELONGATION FACTOR 1 BETA | 1 | 50% | 1% | 1 |
| 9 | GRAFT DISEASE | 1 | 29% | 1% | 2 |
| 10 | CARDIOVASCULAR PROTEOMICS | 1 | 25% | 1% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Biology of atherosclerotic plaques: What we are learning from proteomic analysis | 2006 | 24 | 48 | 33% |
| The -omics era: Proteomics and lipidomics in vascular research | 2012 | 12 | 48 | 15% |
| The Role of Proteomics in Clinical Cardiovascular Biomarker Discovery | 2008 | 28 | 110 | 14% |
| Methodological and Analytic Considerations for Blood Biomarkers | 2012 | 6 | 15 | 20% |
| Proteomics of plaques and novel sources of potential biomarkers for atherosclerosis | 2013 | 6 | 103 | 12% |
| A proteomic portrait of atherosclerosis | 2013 | 3 | 164 | 15% |
| Tissue proteomics in atherosclerosis: elucidating the molecular mechanisms of cardiovascular diseases | 2009 | 4 | 62 | 24% |
| Proteomics-based development of biomarkers in cardiovascular disease - Mechanistic, clinical, and therapeutic insights | 2006 | 37 | 88 | 14% |
| Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective | 2008 | 9 | 86 | 17% |
| Proteomic and metabolomics combined in cardiovascular research | 2007 | 27 | 39 | 13% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | VASC PHYSIOPATHOL | 1 | 21% | 3.0% | 5 |
| 2 | BIOMED SCI BIOTECHNOL HUMAN ANAT | 1 | 50% | 0.6% | 1 |
| 3 | SEZ SCI FARMACOL | 1 | 50% | 0.6% | 1 |
| 4 | HERBAL COSMET SCI | 1 | 29% | 1.2% | 2 |
| 5 | CARDIOL CARDIOVASC PHYSIOL | 0 | 33% | 0.6% | 1 |
| 6 | CNRS BIORAD | 0 | 33% | 0.6% | 1 |
| 7 | FARMACOL CIBEREHD | 0 | 33% | 0.6% | 1 |
| 8 | INSERM UNIT 698 | 0 | 33% | 0.6% | 1 |
| 9 | PROTE PROGRAM | 0 | 33% | 0.6% | 1 |
| 10 | SEKR P 1 1 | 0 | 33% | 0.6% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000184822 | CDNA ARRAY TECHNIQUE//CARDIOVASCULAR GENOMICS//CELLULAR MOL CARDIOL UNIT |
| 2 | 0.0000172720 | TWO DIMENSIONAL POLYACRYLAMIDE GEL ELECTROPHORESIS//MYOCARDIAL PROTEINS//PROTEOME GENE PROD M PING |
| 3 | 0.0000102355 | POLYGONUM MULTIFLORUM//2 3 5 4 TETRAHYDROXYSTILBENE 2 O BETA D GLUCOSIDE//TETRAHYDROXYSTILBENE GLUCOSIDE |
| 4 | 0.0000101590 | SECRETOME//90K MAC 2BP//90K |
| 5 | 0.0000100690 | GLC OXLDL//MOL VASC CELL BIOL//PATHOL AZ MIDDELHEIM |
| 6 | 0.0000094398 | SELDI//SELDI TOF MS//LOW ABUNDANCE PROTEOME |
| 7 | 0.0000079181 | SAMPLE PREFRACTIONATION//PREFRACTIONATION//ALKALINE PROTEINS |
| 8 | 0.0000067892 | URINARY PROTEOMICS//URINARY PROTEOME//URINE PROTEOME |
| 9 | 0.0000066875 | SECT ENDOCRINOL DIABET METAB MC 797//CHOLESTEROL RICH DIETS//APOLIPOPROTEIN E ISOFORMS |
| 10 | 0.0000065302 | PLATELET PROTEOME//EFS AUVERGNE LOIRE//SECT CARDIOIMMUNOL |